Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monocenter, Double Blind, Randomised, Placebo Controlled Study to Evaluate Physostigmine for the Treatment of Delirium in Perioperative Intensive Care Medicine

NCT02216266 is registered in ClinicalTrials.gov with PD Dr. Bertram Scheller as lead sponsor.

NCT NCT02216266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02216266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monocenter, Double Blind, Randomised, Placebo Controlled Study to Evaluate Physostigmine for the Treatment of Delirium in Perioperative Intensive Care Medicine
Lead sponsor
PD Dr. Bertram Scheller
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2014
Completion date
December 31, 2018
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cam-icu diagnosed delirium, suspected delirium after elective or emergency heart surgery